Free
External
Bringing a promising therapy to the clinic is exciting, but the journey from that idea to IND is shaped by a series of critical decisions that can influence development success.
Join Lonza experts, industry leaders and fellow biotech innovators for an afternoon of practical insights, real-world experiences and meaningful connections. Focused on mammalian biologics and antibody-drug conjugates (ADCs), the program will explore key considerations across drug substance and drug product, including CMC, manufacturability, formulation and regulatory strategy.
